HCA Healthcare, Inc. reported Q2 2026 results via an 8-K press release. The full AI analysis of the 10-Q will be generated automatically when it's filed.
HCA Healthcare's second-quarter 2026 revenue increased 8.7% to $20.230 billion, while net income attributable to HCA Healthcare, Inc. increased 2.8% to $1.699 billion.
Revenue
$20.23B
EPS (non-GAAP)
$7.59
Guidance
For 2026, HCA Healthcare revised guidance to revenue of $77.000 billion to $79.500 billion, net income attributable to HCA Healthcare, Inc. of $6.300 billion to $6.700 billion, Adjusted EBITDA of $15.400 billion to $16.100 billion, and diluted EPS of $28.70 to $30.50.
Source: SEC Form 8-K (Item 2.02), EX-99.1 press release. Numbers are company-reported; estimates are Finnhub analyst consensus. This is a same-day snapshot — the full AI analysis (MD&A, risks, audit opinion) is generated automatically when the 10-Q/10-K is filed.
Want the full analysis the moment it's ready? Follow HCA Healthcare, Inc.and we'll notify you when it lands.
Drawn from management commentary in the Q1 2026 10-Q:
Total revenue increased 4.3% YoY to $19.1B in Q1 FY2026, reflecting continued demand for inpatient and outpatient hospital services. This growth is consistent with HCA's strategy of expanding capacity and capturing patient volume across its hospital network.
Operating cash flow jumped 22.0% YoY to $2.01B, significantly outpacing net income growth of 0.6%, indicating strong cash conversion and working capital management. This robust cash generation supports ongoing capital investment and shareholder returns.
Basic EPS grew 11.2% YoY to $7.25 and diluted EPS rose 10.9% to $7.15, meaningfully outpacing net income growth of just 0.6%, reflecting the significant accretive impact of HCA's share buyback program which returned $1.57B to shareholders in the quarter.
Revenue
$19.11B
++4.30% YoY
EPS (Basic)
$7.25
++11.20% YoY
Add HCA to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.